Book a free demo with us
Book Now

Diagnio

Diagnio is a UAE-based innovative HealthTech startup with a mission to transform hormonal diagnostics and help women get a clear understanding of their reproductive health through an accessible, accurate, and comfortable at-home test system. Diagnio generation one device uses a sample of female saliva to measure estrogen levels and determine the cycle phase and ovulation via mobile application. Our team is super experienced in both the startup and corporate worlds, with 15+ years of experience in HealthTech and 5+ years in Medical devices. Our generation one product already has FDA Class 1 clearance, and our startup is backed by Alchemist & ExpertDOJO accelerators in US and IN5 & NRG Ventures in UAE and KSA.

Total Fundraised$5B

PE Round
Late Stage
Debt Financing
Pre-IPO
Series C
Series B
Series A
Others
Calendar Image2022
Established
HeadquarterGradient ImageUnited States
Headquarter
OperationalGradient Image
USA
Operational Market
SectorGradient Image
Healthcare
Healthtech
Hospitals and Health Care
Health Care
Personal Health
mHealth
Women's
Medical
Primary Sector
EmployeeGradient Image1 - 10
Employees
PinGradient ImagePre-Seed
Current Stage
GlobeGradient Imagehttps://diagnio.com/
Website

Funding Types by Funds Raised (in USD)

Content Locked

Login or Register a FREE account to continue browsing our content

Cumulative Funding Raised Over Time

Content Locked

Login or Register a FREE account to continue browsing our content

Diagnio's Investors by Funding Rounds

Funding Round

Announced Date

Disclosed Investors

Round Amount (USD)

Content Locked

Login or Register a FREE account to continue browsing our content

Diagnio's Key
Team Members

Marina Sol